Aesthetic medicine is transforming/moving from surgery to smart, minimally invasive injectable treatments that combine science and innovation for natural, rejuvenated results. From dermal fillers to regenerative injectables, these products are reshaping beauty with safer, faster, and more personalized outcomes.
But as the market grows, regulatory compliance under EU MDR Annex XVI becomes essential. Discover how 1MED SA supports manufacturers in designing clinical investigations, ensuring MDR compliance, and collecting real-world evidence through 1Survey, its digital post-market solution.
Learn how science, regulation, and innovation come together to shape the future of aesthetic injectables.
Download the full article to explore more.